← Open Payments lookup

AMY PARISI: Open Payments

NPI 1053836429 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$281 in 13 payments from 8 companies in 2025. Trend: 2023 $48 · 2024 $231 · 2025 $281

Food & beverage: $281
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.4$90
ABBVIE INC.2$51
Neurocrine BioSciences, Inc.2$29
Lundbeck LLC1$27
Takeda Pharmaceuticals U.S.A., Inc.1$24
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$22
Novo Nordisk Inc1$19
Tris Pharma Inc1$18

Products named: REXULTI, VRAYLAR, INGREZZA, TRINTELLIX, ABILIFY MAINTENA, CAPLYTA, Wegovy, Dyanavel XR.

Industry payments across DE — which companies pay providers there.